Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.

Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...

For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...

Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...

CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...

PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted the latest update to the American Urological Association (AUA) Guidelines for the management of lower urinary tract symptoms (LUTS) attributed to ...

A new treatment for an enlarged prostate is gaining popularity among doctors in Southwest Florida. The innovative procedure offers relief without traditional surgery. James Crumbaugh, a patient who ...

Scottsdale, Ariz.-based East Valley Urology has completed the first three prostate cancer procedures in PROCEPT BioRobotics’ FDA-approved WATER IV trial using Aquablation therapy. The outpatient ...

Two interventions to treat large prostates produced similar symptom relief but had different effects on prostate volume and different adverse event profiles, a large randomized trial showed. Baseline ...